Multifactorial Treatment of Cardiovascular Risk in Diabetic Patients: Identification of Treatment Non-Responders

NCT00660790 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2021-03-19

Study results available
· View outcomes & findings →

Summary

The aim of the study is to develop a model that allows early identification of type-2 diabetic patients who will face progressive atherosclerosis despite intensive, multifactorial, target oriented treatment

Conditions

  • Diabetes Mellitus, Type II

Interventions

OTHER

Intensified Treatment of risk factors

Patients received a target oriented, intensified treatment of risk factors according to current national treatment guidelines

Sponsors & Collaborators

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Harald Sourij, MD · Department of Internal Medicine, Medical University of Graz, Austria

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-04-30
Primary Completion
2012-07-31
Completion
2012-07-31

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00660790 on ClinicalTrials.gov